JDRF @ ADA 73rd Scientific Sessions: Friday Summary

Welcome to our daily summary of type 1 diabetes (T1D) research highlights from the ADA’s 73rd Scientific Sessions!  Each night, we will be posting summaries of notable sessions and presentations.  Below are two relevant sessions from Friday, June 21.  Beta Cell Failure in Type 1 Diabetes – Cause or Consequences? The fact that T1D is a complicated […]

A Guide to JDRF’s Presence at the American Diabetes Association’s 73rd Scientific Sessions

JDRF-supported research is at the forefront of the American Diabetes Association’s (ADA) 73rd Scientific Sessions this year, June 21-24 in Chicago, with 13 oral presentations, 14 poster presentations, three symposium discussions, one scientific workshop, more than a dozen meetings with research partners, and 20 JDRF staff and senior leadership in attendance to represent scientific progress […]

Testing an Artificial Pancreas System

Living with type 1 diabetes (T1D) requires constant care and attention: blood-glucose monitoring, carbohydrate counting, insulin dosing, and monitoring for high and low blood-glucose levels. But new technology is changing T1D management—and for the good. Just ask Tom Brobson, JDRF’s national director of research investment opportunities, who has doubled as a test subject for JDRF’s […]

Discovery of New Hormone May Impact T1D

The media has come alive, exciting the type 1 diabetes (T1D) community, following the publication of findings of a new hormone in Cell on April 25. The previously unknown hormone, called betatrophin, was found in a mouse study to have the unique ability to promote the natural replication of insulin-producing beta cells. While media reports […]

Workshop Explores Progress of Artificial Pancreas Systems

Leading experts from industry, academia, and government came together in early April in Bethesda, MD, to discuss innovation in the development of an artificial pancreas at a workshop hosted by the National Institutes of Health, the Food and Drug Administration (FDA), and JDRF. Artificial pancreas systems will automate insulin delivery and likely other hormones in […]

JDRF Capitol Chapter Hosts Research Summit

Shared connections to type 1 diabetes (T1D) brought together more than 600 people at the recent JDRF Type 1 Diabetes Research Summit held in Washington, D.C. Hosted by the JDRF Capitol Chapter, this one-day event was filled with informative, easy-to-understand presentations by top T1D researchers. Attendees had the opportunity to hear directly from these top […]

JDRF Convenes First-Ever Encapsulation Consortium

For people living with type 1 diabetes (T1D), establishing insulin independence by implanting insulin-producing beta cells into the body would be life changing. But a challenge to this potential therapy lies in the body’s immune system, which recognizes the implanted beta cells as foreign entities or invaders and subsequently attacks them. Furthermore, the implanted beta […]

JDRF-Led Workshop Explores Progress toward an Artificial Pancreas System

Leading experts from industry, academia, and government came together the second week of April in Bethesda, MD, to discuss innovation in the development of an artificial pancreas system at a workshop hosted by the National Institutes of Health, the Food and Drug Administration (FDA), and JDRF. A commercially-viable artificial pancreas system would mimic the biological […]